Quest Diagnostics (NYSE:DGX)報告的季度每股收益爲$2.23，超過分析師預期的$2.19，超出1.83%。這是相比去年同期每股收益$2.15增長了3.72%。公司報告的季度銷售額爲$26.2億，超過分析師預期的$25.8億，超出1.65%。相比去年同期銷售額$22.9億增長了14.55%。
以上內容來自Benzinga Earnings專欄，原文如下：
Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $2.19 by 1.83 percent. This is a 3.72 percent increase over earnings of $2.15 per share from the same period last year. The company reported quarterly sales of $2.62 billion which beat the analyst consensus estimate of $2.58 billion by 1.65 percent. This is a 14.55 percent increase over sales of $2.29 billion the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。